Monsanto (MON) Given News Sentiment Rating of 0.01

News articles about Monsanto (NYSE:MON) have been trending somewhat positive this week, Accern Sentiment reports. Accern identifies positive and negative news coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Monsanto earned a media sentiment score of 0.01 on Accern’s scale. Accern also assigned news headlines about the basic materials company an impact score of 45.4401008167195 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Here are some of the headlines that may have effected Accern Sentiment’s rankings:

Monsanto (NYSE MON) traded down $0.70 during trading hours on Monday, hitting $117.30. 5,241,700 shares of the stock were exchanged, compared to its average volume of 1,971,064. Monsanto has a 52 week low of $104.08 and a 52 week high of $122.79. The company has a quick ratio of 0.83, a current ratio of 1.35 and a debt-to-equity ratio of 1.12. The company has a market capitalization of $51,740.00, a PE ratio of 21.21, a P/E/G ratio of 1.69 and a beta of 1.04.

Monsanto (NYSE:MON) last posted its earnings results on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.41) by $0.61. Monsanto had a net margin of 15.44% and a return on equity of 42.40%. The company had revenue of $2.69 billion during the quarter, compared to analysts’ expectations of $2.51 billion. During the same quarter in the previous year, the company posted $0.07 earnings per share. Monsanto’s quarterly revenue was up 4.8% compared to the same quarter last year. analysts anticipate that Monsanto will post 5.74 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Friday, January 5th will be paid a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.84%. The ex-dividend date is Thursday, January 4th. Monsanto’s dividend payout ratio (DPR) is currently 42.52%.

A number of research analysts have commented on the stock. Zacks Investment Research cut shares of Monsanto from a “buy” rating to a “hold” rating in a research note on Monday. Barclays restated an “equal weight” rating and set a $124.00 price target (up previously from $120.00) on shares of Monsanto in a research note on Thursday, October 5th. BMO Capital Markets restated a “buy” rating and set a $128.00 price target on shares of Monsanto in a research note on Thursday, October 5th. Wells Fargo & Company raised their price target on shares of Monsanto from $107.50 to $118.00 and gave the stock a “market perform” rating in a research note on Tuesday, October 10th. Finally, UBS cut shares of Monsanto from a “buy” rating to a “neutral” rating and set a $128.00 price target for the company. in a research note on Friday, August 18th. Twelve analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Monsanto presently has a consensus rating of “Hold” and an average price target of $124.61.

In related news, EVP Steven Mizell sold 11,526 shares of the firm’s stock in a transaction that occurred on Monday, October 9th. The shares were sold at an average price of $119.70, for a total value of $1,379,662.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, VP Nicole M. Ringenberg sold 7,890 shares of the firm’s stock in a transaction that occurred on Monday, October 16th. The shares were sold at an average price of $122.25, for a total transaction of $964,552.50. Following the completion of the sale, the vice president now directly owns 38,600 shares of the company’s stock, valued at approximately $4,718,850. The disclosure for this sale can be found here. Insiders sold 49,236 shares of company stock valued at $5,931,934 in the last quarter. 0.79% of the stock is currently owned by corporate insiders.

ILLEGAL ACTIVITY NOTICE: This piece of content was first published by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this piece of content on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece of content can be accessed at

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Insider Buying and Selling by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply